| 000 | 03932naaaa2201021uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/41945 | ||
| 005 | 20220219202549.0 | ||
| 020 | _abooks978-3-03921-276-7 | ||
| 020 | _a9783039212750 | ||
| 020 | _a9783039212767 | ||
| 024 | 7 |
_a10.3390/books978-3-03921-276-7 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 100 | 1 |
_aFernandez-Quintela, Alfredo _4auth |
|
| 700 | 1 |
_aPortillo, María P. _4auth |
|
| 245 | 1 | 0 | _aBenefits of Resveratrol Supplementation |
| 260 |
_bMDPI - Multidisciplinary Digital Publishing Institute _c2019 |
||
| 300 | _a1 electronic resource (260 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aIn recent years, great attention has been paid to polyphenols due to their positive effects on health. One of the most widely-studied phenolic compounds is resveratrol. This molecule, which is naturally present in some foods, shows beneficial effects on various physiological and biochemical processes, thus representing a potential tool for the prevention or the treatment of diseases highly prevalent in our society. Several of these beneficial effects have been observed in human beings, but others only in pre-clinical studies so far, and therefore, it is mandatory to continue with the scientific research in this field. Indeed, new knowledge concerning these issues could enable the development of novel functional foods or nutraceuticals, incorporating resveratrol, suitable for preventing or treating diseases such as cancer, cardiovascular diseases, obesity, dislipemia, insulin resistance and diabetes, liver diseases, etc. | ||
| 540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by-nc-nd/4.0/ _2cc _4https://creativecommons.org/licenses/by-nc-nd/4.0/ |
||
| 546 | _aEnglish | ||
| 653 | _apolyphenols | ||
| 653 | _a?-viniferin | ||
| 653 | _aleptin resistance | ||
| 653 | _ap53 | ||
| 653 | _akidney | ||
| 653 | _aenergy restriction | ||
| 653 | _agrape powder extract | ||
| 653 | _acytokines | ||
| 653 | _aphosphorylation | ||
| 653 | _aobesity | ||
| 653 | _aenergy metabolism | ||
| 653 | _ametabolic pathways | ||
| 653 | _aendothelial function | ||
| 653 | _apolyol pathway | ||
| 653 | _aantioxidant | ||
| 653 | _acaloric restriction | ||
| 653 | _arat | ||
| 653 | _aadipose tissue | ||
| 653 | _amicroparticles | ||
| 653 | _apathways | ||
| 653 | _aangiotensin converting enzyme 2 | ||
| 653 | _aresistance | ||
| 653 | _aesRAGE | ||
| 653 | _ainterleukins | ||
| 653 | _ametabolic syndrome | ||
| 653 | _adissolution rate | ||
| 653 | _athermogenesis | ||
| 653 | _astreptozotocin | ||
| 653 | _abioavailability | ||
| 653 | _asolubility | ||
| 653 | _ametabolism | ||
| 653 | _arenin-angiotensin system | ||
| 653 | _amicrobiota | ||
| 653 | _aSirt-1 | ||
| 653 | _amagnesium dihydroxide | ||
| 653 | _ahypertrophy | ||
| 653 | _ametabolic diseases | ||
| 653 | _aphysiological adaption | ||
| 653 | _ared wine extract | ||
| 653 | _alens | ||
| 653 | _adistribution | ||
| 653 | _aMTA1 | ||
| 653 | _asirtuin | ||
| 653 | _ainflammation | ||
| 653 | _acardiac function | ||
| 653 | _arats | ||
| 653 | _acisplatin | ||
| 653 | _aresveratrol | ||
| 653 | _amitochondria | ||
| 653 | _abreast cancer | ||
| 653 | _aischemia-reperfusion | ||
| 653 | _acardiovascular | ||
| 653 | _ametabolites | ||
| 653 | _agut microbiota | ||
| 653 | _aprostate cancer | ||
| 653 | _aperformance | ||
| 653 | _atype 2 diabetes | ||
| 653 | _acafeteria diet | ||
| 653 | _ahigh-fat high-sucrose diet | ||
| 653 | _aresistance exercise | ||
| 653 | _aaging | ||
| 653 | _adiabetes | ||
| 653 | _aoxidative stress | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://mdpi.com/books/pdfview/book/1443 _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/41945 _70 _zDOAB: description of the publication |
| 999 |
_c41696 _d41696 |
||